Product
roxadustat
Aliases
ASP1517
2 clinical trials
2 indications
Indication
chronic kidney diseaseIndication
Chronic Kidney Disease with AnemiaClinical trial
A Phase 3 Multi-center, Randomized, Open-label, Active-comparator (Darbepoetin Alfa) Conversion Study of Intermittent Oral Dosing of ASP1517 in Non-dialysis Chronic Kidney Disease Patients With AnemiaStatus: Completed, Estimated PCD: 2019-09-13
Clinical trial
A Phase 3, Multi-center, Randomized, 2-arm Parallel, Double-blind, Active-comparator (Darbepoetin Alfa) Conversion Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With AnemiaStatus: Completed, Estimated PCD: 2018-03-13